✦ LIBER ✦

4–49 Zoledronic Acid Inhibits Adjuvant Letrozole–Induced Bone Loss in Postmenopausal Women With Early Breast Cancer

Book ID: 123146627
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 62 KB
Volume: 18
Category: Article
ISSN: 1043-321X
DOI: 10.1016/S1043-321X(07)80431-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Zoledronic Acid Inhibits Adjuvant Letroz

Zoledronic Acid Inhibits Adjuvant Letrozole-Induced Bone Loss in Postmenopausal Women With Early Breast Cancer

✍ Brufsky, Adam (author);Harker, W. Graydon (author);Beck, J. Thaddeus (author);Ca 📂 Article 📅 2007 🏛 American Society of Clinical Oncology 🌐 English ⚖ 176 KB

Zoledronic Acid Inhibits Adjuvant Letroz

Zoledronic Acid Inhibits Adjuvant Letrozole-Induced Bone Loss in Postmenopausal Women With Early Breast Cancer

✍ Brufsky, Adam (author);Harker, W. Graydon (author);Beck, J. Thaddeus (author);Ca 📂 Article 📅 2007 🏛 American Society of Clinical Oncology 🌐 English ⚖ 176 KB

Effective inhibition of aromatase inhibi

Effective inhibition of aromatase inhibitor-associated bone loss by zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole : ZO-FAST study results

✍ Nigel J. Bundred; Ian D. Campbell; Neville Davidson; Richard H. DeBoer; Holger E 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 158 KB

## Abstract ## BACKGROUND. Letrozole is safe and effective in postmenopausal women with estrogen receptor‐positive early breast cancer, but long‐term aromatase inhibitor use may cause bone loss and increase fracture risk. This study evaluated an immediate or delayed strategy of bone protection the

P105 Zoledronic acid in the prevention o

P105 Zoledronic acid in the prevention of cancer treatment-induced bone loss in postmenopausal women receiving letrozole as adjuvant therapy for early breast cancer

✍ N. Davidson; P. Neven; A. Llombart; N. Bundred; A. Monnier; R. DeBoer; G. Giardi 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 143 KB

Zoledronic acid in the prevention of can

Zoledronic acid in the prevention of cancer treatment-induced bone loss in postmenopausal women receiving letrozole as adjuvant therapy for early breast cancer (ZO-FAST study)

✍ N. Bundred; Campbell; R. Coleman; R. DeBoer; H. Edidtmann; A. Frassolati; A. Llo 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 126 KB

0159 Zoledronic acid protective effect o

0159 Zoledronic acid protective effect on bone loss in postmenopausal women with early breast cancer switched from tamoxifen to letrozole

✍ T. Safra; R. Bernstein Molho; I. Stephansky; N. Yaal-Hahoshen; M. Inbar; A. Acke 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 53 KB